Advanced Human Imaging Limited (AHI)
$1.96
-0.01 (-0.25%)
Rating:
Recommendation:
-
| Symbol | AHI |
|---|---|
| Price | $1.96 |
| Beta | 1.497 |
| Volume Avg. | 0.06M |
| Market Cap | 16.370M |
| Shares () | - |
| 52 Week Range | 0.64-15.52 |
| 1y Target Est | - |
| DCF Unlevered | AHI DCF -> | |
|---|---|---|
| DCF Levered | AHI LDCF -> | |
| ROE | -605.42% | Strong Sell |
| ROA | -212.86% | Strong Sell |
| Operating Margin | - | |
| Debt / Equity | 88.93% | Buy |
| P/E | -6.12 | Strong Sell |
| P/B | 305.71 | Strong Buy |
Latest AHI news
About
Download (Excel)Mr. Scott Montgomery
Technology
Software—Application
NASDAQ Capital Market
Advanced Human Imaging Limited operates as a mobile application and technology development company worldwide. It develops and patents a proprietary measurement/dimensioning technology that enables end-user to check, track, and assess body dimensions privately using a smartphone. The company offers smartphone-based human scanning technology, such as BodyScan, FaceScan, DermaScan, MKScan, and HemaScan. It serves mobile health and telehealth, life and health insurance, fitness and wellness, and consumer apparel sectors. The company was formerly known as MyFiziq Limited and changed its name to Advanced Human Imaging Limited in March 2021. Advanced Human Imaging Limited was incorporated in 2014 and is based in South Perth, Australia.